SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001116679-05-002118
Filing Date
2005-08-12
Accepted
2005-08-12 17:16:18
Documents
1
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 5  
1 PRIMARY DOCUMENT edgar.xml 5 10579
  Complete submission text file 0001116679-05-002118.txt   12506
Mailing Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154
Business Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154 212-750-6700
BIOENVISION INC (Issuer) CIK: 0001028205 (see all company filings)

IRS No.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address BIOENVISION, INC. 509 MADISON AVE., SUITE 404 NEW YORK NY 10022
Business Address 212-318-6700
Griffith Hugh (Reporting) CIK: 0001296964 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-31787 | Film No.: 051022676